|
SFRS7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.53210777398272E-14 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62614366416847E-12 |
| Stage1-vs-Stage2 |
1.480690E-03 |
| Stage1-vs-Stage3 |
2.906000E-02 |
| Stage1-vs-Stage4 |
9.316500E-03 |
| Stage2-vs-Stage3 |
1.552800E-01 |
| Stage2-vs-Stage4 |
5.556000E-01 |
| Stage3-vs-Stage4 |
3.982800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
6.03140000055014E-07 |
| Normal-vs-Asian |
6.52079945595574E-10 |
| Caucasian-vs-AfricanAmerican |
5.594400E-01 |
| Caucasian-vs-Asian |
3.823800E-01 |
| AfricanAmerican-vs-Asian |
9.564600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
1.419560E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62481139653892E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
2.218500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.386080E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.740030E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.270400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.529000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.507800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.215200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.360900E-03 |
| Classical-VS-Follicular |
5.499100E-03 |
| Classical-VS-Other |
4.094000E-01 |
| Classical-VS-Normal |
7.40951744404583E-12 |
| Tall-VS-Follicular |
6.097600E-01 |
| Tall-VS-Other |
4.690400E-01 |
| Tall-VS-Normal |
1.68887126505979E-12 |
| Follicular-VS-Other |
7.648600E-01 |
| Follicular-VS-Normal |
1.69553260320754E-12 |
| Other-VS-Normal |
3.614000E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
2.38790098805453E-11 |
| N0-vs-N1 |
6.306200E-01 |
|
|
